The Epoch Times
The Epoch Times
Focus

Ensitrelvir

Asia & Pacific
Asia & Pacific
|
Ellen Wan, Angela Bright

Japanese Company Says New Oral COVID-19 Drug Ensitrelvir Achieves Primary Endpoint

Nov 18, 2022
|
Ellen Wan
FacebookXTruthGettrLinkedInTelegramEmail
Japanese Company Says New Oral COVID-19 Drug Ensitrelvir Achieves Primary Endpoint
Nov 18
|
FacebookXTruthGettrLinkedInTelegramEmail
Asia & Pacific
Asia & Pacific
|
Ellen Wan, Angela Bright

Japanese Company Says New Oral COVID-19 Drug Ensitrelvir Achieves Primary Endpoint

Nov 18, 2022
|
Ellen Wan
FacebookXTruthGettrLinkedInTelegramEmail
Japanese Company Says New Oral COVID-19 Drug Ensitrelvir Achieves Primary Endpoint
Nov 18
|
FacebookXTruthGettrLinkedInTelegramEmail
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.